BRAVE Study Investigates Adenosine Pathway in Drug-Resistant Epilepsy and SUDEP Risk
The BRAVE study, sponsored by Hospices Civils de Lyon, is currently investigating alterations in adenosine receptors (ARs) within the brainstem of patients with drug-resistant epilepsy. This trial specifically examines the relationship between these receptor alterations and respiratory dysfunction,